Featured Stories
Zadroga Act Cancer Decision Expected This Week

Zadroga Act Cancer Decision Expected This Week

The federal official tasked with determining what ailments should be covered by the federal Zadroga Act is expected to decide by Saturday if certain cancers will be eligible for compensation. The decision is being eagerly awaited by thousands of first responders who believe they developed cancer due to exposure ...

Read More

First DePuy ASR Hip Implant Lawsuits Head to Trial in December, January

First DePuy ASR Hip Implant Lawsuits Head to Trial in December, January

The first trials involving lawsuits filed against DePuy Orthopaedics by recipients of its recalled ASR Hip Implants will begin later this year, and early next year. The first is slated to start on December 3, 2012 in state court in Las Vegas, Nevada. A second DePuy ASR hip implant lawsuit ...

Read More

Actos Bladder Cancer Lawsuit Filed by West Virginia Resident

Actos Bladder Cancer Lawsuit Filed by West Virginia Resident

Actos (pioglitazone) continues to be named in lawsuits alleging long-term use of the type 2 diabetes drug caused patients to develop bladder cancer. Just last week, the national law firm of Parker Waichman LLP filed suit against Takeda Pharmaceuticals on behalf of a West Virginia man who developed bladder cancer ...

Read More

Stryker Issues Voluntary Recall for Rejuvenate Modular and ABG II Hip Implant Components

Stryker Issues Voluntary Recall for Rejuvenate Modular and ABG II Hip Implant Components

Stryker Orthopedics is recalling two metal-on-metal hip implant components, its Rejuvenate Modular and ABG II modular-neck hip stems. According to a notice posted on Stryker’s website, risks associated with the Rejuvenate Modular and ABG II modular-neck hip stems include the potential for fretting and/or corrosion at or about ...

Read More

Knee Replacement Patients Should Consider Nickel Allergies before Surgery

Knee Replacement Patients Should Consider Nickel Allergies before Surgery

Individuals considering undergoing knee replacement surgery should ask their doctors to run a test to determine if they have a nickel allergy. Determining if a patient suffers from a nickel allergy will ensure the right knee implant is chosen for their surgery, and possibly save them from considerable pain and ...

Read More

Study Linking Z-Pak to Increased Death Risk Being Reviewed by FDA

Study Linking Z-Pak to Increased Death Risk Being Reviewed by FDA

The U.S. Food & Drug Administration (FDA) is reviewing a new study that reported an increased risk of sudden, heart-related deaths among people using the antibiotic Zithromax (azithromycin), known popularly as Z-Pak. In a statement issued late yesterday, the FDA said patients being treated with Zithromax should not stop taking ...

Read More

Stryker Metal Hip Implant Component Recall Bad News for Makers of Metal-on-Metal Hip Replacement Devices

Stryker Metal Hip Implant Component Recall Bad News for Makers of Metal-on-Metal Hip Replacement Devices

Stryker’s recent recall of two metal hip implant components, the Rejuvenate Modular and ABG II modular-neck hip stems, may have dealt a serious blow to one of the key arguments medical device manufacturers have made to defend their metal-on-metal hip replacements. Facing thousands of lawsuits, the makers of ...

Read More

FDA Advisory Panel Wrestling with Metal-on-Metal Hip Replacement Safety

FDA Advisory Panel Wrestling with Metal-on-Metal Hip Replacement Safety

An advisory panel for the U.S. Food & Drug Administration (FDA) began a highly-anticipated meeting yesterday to discuss the safety of metal-on-metal hip implants. Among other things, the panel of outside experts is being asked to make recommendations regarding the best practices for monitoring patients with metal-on-metal hip replacements. ...

Read More

Parker Waichman Representing Another Louisiana Plaintiff in Actos Bladder Cancer Lawsuit

Parker Waichman Representing Another Louisiana Plaintiff in Actos Bladder Cancer Lawsuit

A Louisiana man has become the latest to claim that his taking the type 2 diabetes drug Actos resulted in developing bladder cancer. He has filed a lawsuit against the Japanese manufacturer of the drug and the marketer of it in the U.S., claiming they failed to warn about this ...

Read More

Study Finds Metal-on-Metal Hip Implants Associated with High Incidence of Pseudotumors

Study Finds Metal-on-Metal Hip Implants Associated with High Incidence of Pseudotumors

Yet another study is adding to concerns about the potential dangers associated with metal-on-metal hip implants. The study, published in the Journal of Bone and Joint Surgery, found that large diameter metal-on-metal total hip replacement may be associated with a substantially higher incidence of pseudotumor formation.

Read More

Newer Joint Replacement Systems May Offer No Benefit

According to a systematic review published online September 9th in the BMJ, there is no evidence to support the use of 5 newer joint replacement devices compared to analogous products that have been on the market longer. In fact, the risk of undergoing revision surgery is higher with some of the newer systems.

The study was led by Marc J. Nieuwenhuijse, MD, PhD from the Patient Centered Comparative Effectiveness Program and US Food and Drug Administration Medical Device Epidemiology Science and Infrastructure Center, Department of Public Health, Weill Cornell Medical College, New York, City; the Department of Orthopaedics, Leiden University Medical Center, the Netherlands; and the Office of Surveillance and Biometrics, Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, MD. He and his colleagues wrote that “[N]ew technologies are being introduced to the commercial market without sufficient high quality evidence for improved benefit over existing, well proven, and safe alternative implant solutions…[T]he status quo regarding the introduction of new device technologies is not acceptable.” Continue reading

Posted in Legal News |

Nineteen Deaths Linked to GM Ignition Switch Defect

Kenneth Feinberg, the attorney overseeing the General Motors compensation fund, has so far linked 19 deaths to a serious flaw with the ignition switches, a higher number than the 13 deaths GM had acknowledged in crashes resulting from the switch problem.

The fund has received 125 death claims and 320 injury claims in the five weeks it has been operating. Feinberg has found 31 claims eligible for compensation, CNN Money reports. Continue reading

Posted in Accident, Defective Products, Motor Vehicles, Product Recalls, Recalled Vehicles |

Fracking Workers Exposed to High Levels of Benzene, Study Finds

Workers at hydraulic fracturing – fracking – oil and gas sites are routinely exposed to high levels of benzene, according to a study by the National Institute for Occupational Safety and Health (NIOSH).

The agency, part of the Centers for Disease Control and Prevention (CDC), recommends that workers limit their benzene exposure to an average of 0.1 of a part per million during their shift. But when the researchers measured airborne benzene workers would be exposed to when they opened hatches on tanks at well sites, 15 of 17 samples exceeded that amount, the Los Angeles Times reports. Benzene levels at the wells “reached concentrations that, depending on the length of exposure, potentially pose health risks for workers,” the researchers wrote in the Journal of Occupational and Environmental Hygiene. Workers must open the hatches one to four times per hour to inspect and measure the contents. Continue reading

Posted in Benzene, Health Concerns, Hydraulic Fracturing / Fracking |

Popular Acne Treatment can Cause Life-Threatening Allergic Reactions, FDA Warns

Over-the-counter (OTC) acne treatments are widely available and frequently used, but the U.S. Food and Drug Administration (FDA) has warned that some may lead to life-threatening allergic reactions.

Signs of an allergic reaction include tightness in the throat, difficulty breathing, feeling faint, swelling of the eyes, face, lips or tongue and hives or itching in the area where the treatment was used. Consumers should stop using the product and seek medical attention immediately if they experience a reaction. Continue reading

Posted in Legal News |

DePuy Pinnacle Trial Proceeds, More DePuy Witnesses Testify

The DePuy Pinnacle bellwether trial continues, as DePuy witnesses continue to testify. The trial, which began on September 2nd in the U.S. District Court for the Northern District of Texas in Dallas before U.S. District Judge Ed Kinkeade, is expected to last 6 to 8 weeks. Nine people, 5 women and 4 men, are on the jury. Continue reading

Posted in Legal News |

Jalapeno Bagels Recalled‏ for Potential Glass, Stones

The U.S. Food and Drug Administration (FDA) just announced that Publix has issued a recall of its private label jalapeno bagels: Publix Jalapeno Bagels.

The Publix Jalapeno Bagels were sold in the stores’ self-service bins or in the artisan cases in the stores’ bakery departments. The recalled bagels may contain pieces of glass and small stones. The product supplier advised Publix of the potential product hazard. Continue reading

Posted in Defective Products, Food Poisoning, Health Concerns, Product Recalls, Recalled Food Products |

Ethicon TVT-O Sling Pelvic Mesh Trial Update: $3.27 Million Verdict Reached

Ethicon-Sling-Pelvic-Mesh-Verdict-ReachedA West Virginia jury has reached a $3.27 million verdict in a federal bellwether product liability case brought over the Ethicon transvaginal TVT-O sling. Transvaginal mesh implants are used to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI); Ethicon is a unit of Johnson & Johnson.

The jury ordered that Ethicon must pay the multi-million compensatory damages amount in a case that included allegations that the its TVT-O transvaginal sling was defectively designed. Allegations also included that Ethicon neglected to warn the public about the device’s potential risks, wrote Law360. Although punitive damages have not been awarded, the jury found in favor of the plaintiff on all counts: Strict liability, design defect, failure to warn, and negligence. Continue reading

Posted in Defective Medical Devices, Transvaginal mesh |

Lawmakers to Introduce 25-Year Extension of Zadroga 9/11 Health and Compensation Act

zadroga-act-extensionA group of lawmakers, first responders, and community and labor leaders gathered at Ground Zero on September 8 to begin an effort to reauthorize the James Zadroga 9/11 Health and Compensation Act for another 25 years.

The Zadroga Act was passed in December 2010 to provide medical treatment and compensation for 9/11 first responders, recovery workers and volunteers, and community survivors. Later this month, U.S. Senators Kirsten Gillibrand and Chuck Schumer will introduce the Zadroga Act reauthorization to extend the programs through 2041. Continue reading

Posted in Health Concerns, Toxic Substances, UPS Broken Shipment Complaints, Zadroga Act Claims |

Attorney Says J&J Was Aware of Hip Implant Metal Poisoning Concern in 2001

12hip-span-videoSixteenByNine1050In a lawsuit being tried in U.S. District Court in Dallas, Texas, an attorney said Johnson & Johnson knew in 2001 of concerns about metal poisoning with the DePuy Pinnacle artificial hip.

Dr. Thomas Schmalzreid, a doctor who consulted with DePuy on the development of the hip, told the company in February 2001 that implant patients should be tested to determine whether they had metal debris in their bloodstreams, Bloomberg News reports. In an internal memo, DePuy officials Schmalzried warned about the possible release of metal ions as the parts of the hip rubbed against each other during normal activity. He called this a “major issue for metal-on-metal hips.” Andrew Ekdahl, former president of DePuy and now chairman of J&J’s DePuy Synthes unit, denied that company officials considered reducing marketing efforts because of these concerns. Continue reading

Posted in Defective Medical Devices, Depuy, Legal News, Metal Hip Implants |

Study Finds Association Between Viagra Use and Melanoma

Tabletten zur PotenzsteigerungThe popular erectile dysfunction drug, Viagra (sildenafil citrate), has been associated with increased risks for the skin cancer, melanoma. Viagra is manufactured by Pfizer Inc. and is a phosphodiesterase (PDE) 5A inhibitor (PDE5A) that is typically used in the treatment of erectile dysfunction (ED). The drug received U.S. Food and Drug Administration (FDA) approval in 1998.

The research revealed that men who used Viagra and other sildenafil drugs were 84 percent likelier to receive a melanoma diagnosis. Melanoma is the deadliest of the skin cancers and, according to a prior The Associated Press report, more than three-quarters of all deaths related to skin cancer involve melanoma and approximately one person dies from melanoma every hour in the United States. Continue reading

Posted in Pharmaceuticals |

© 2005-2014 Parker Waichman LLP ®. All Rights Reserved.